Podcast

In this episode of the In Vivo podcast Michelle Werner, CEO of Alltrna, discusses using tRNA as a therapeutic modality for rare diseases.

Israeli-American biotech Immunai is mapping the immune system and using AI to predict immune responses to drugs.